Good morningʻ dear all. Want to discuss a tricky case for your inputs.

Good morningʻ dear all. Want to discuss a tricky case for your inputs. A young male, medico, is currently admitted with acute non positional constant vertigo for about 1 week now. At presentation, he had subtle left beat unidirectional nystagmus, HIT negative, Romberg positive ( mild), sense of instability on walking. Next day, nystagmus became right beating and remains so for 2 days now. Nystagmus is more on removing fixation and slightly increases on right McClure pagnini but no crescendo decrescendo or latency or increased symptom severity in that position ( negative positional test). HIT remains negative ( F-HIT twice done, normal and clinical HIT also negative) No aural symptoms. H/o episodic migrainous headaches is there in past. MRI brain contrast, CTAngio, PTA all normal. Patient not responding to flunarizine, iv solumedrol ( 40mg given one day and 250 mg on 2nd day). Betahistine is ineffective. Symptoms are rather escalating. Gave stemetil 5mg- again no significant effect. Looking for valuable suggestions

Reading Document

Medical Text Search

direction changing nystagmus spontaneous central vertigo differential diagnosis

Medical Text Search

vestibular neuritis treatment failure escalating symptoms management

GradeResponse

This is a rich, nuanced case. Let me synthesize a comprehensive analysis.

Clinical Analysis: Acute Sustained Vertigo with Direction-Changing Nystagmus

The Key Red Flags in This Case

Before anything else, the combination of findings here is highly concerning for a central cause, and the clinical picture needs urgent re-evaluation even with a "normal" MRI.

Feature	Peripheral Implication	This Patient
Nystagmus direction	Fixed, unidirectional	Changed direction (L → R beat)
HIT	Positive (canal paresis)	Negative x3 (clinical + F-HIT x2)
Fixation suppression	Suppresses nystagmus	Enhanced on removal of fixation
Duration	Improves within days	Worsening at 1 week
Response to treatment	Typically responds	No response to steroids, antiemetics, betahistine
Positional component	Classic BPPV pattern	Atypical — no latency/crescendo-decrescendo

As per Harrison's (p. 721): "Nystagmus that changes direction with gaze is due to a central lesion" and "Absence of a head impulse sign in a patient with acute prolonged vertigo should suggest a central cause."

The Direction-Changing Nystagmus — What It Means

The nystagmus changed from left-beating to right-beating over 24–48 hours. This is critical:

Peripheral nystagmus is fixed and unidirectional by Alexander's Law. Direction-reversal of spontaneous nystagmus is a central sign. The differential for this specific pattern includes:

Central Vestibular Migraine (Vestibular Migraine with central features)
Brainstem / cerebellar lesion — particularly affecting the:
- Nodulus/uvula of cerebellum (can produce direction-changing positional nystagmus)
- Nucleus prepositus hypoglossi / MVN (velocity storage mechanism)
MS plaque in brainstem or vestibular nuclei
Wernicke's encephalopathy (given he's a young medico — consider nutrition/stress)
Autoimmune encephalitis (anti-NMDAR, LGI1, CASPR2 — can present with isolated brainstem/vestibular symptoms)
Episodic ataxia type 2 (EA2) — CACNA1A mutation, can mimic this pattern

Why Vestibular Migraine Doesn't Fully Fit

Yes, he has a migrainous history — but several features argue against pure vestibular migraine:

Continuous (non-episodic) vertigo for 1 week
Direction reversal of nystagmus — unusual even for VM
No response to flunarizine (a calcium channel blocker commonly used in VM)
Escalating rather than plateauing symptoms

VM typically produces episodic vertigo. A sustained 1-week continuous course with worsening and direction-changing nystagmus pushes toward central structural or inflammatory pathology.

MRI Was "Normal" — But Is It Truly Negative?

This is the most important caveat. MRI can miss posterior fossa pathology, especially early:

Acute cerebellar/brainstem infarcts can be MRI-invisible in the first 24–72 hours on DWI (false-negative DWI rate for posterior fossa infarcts is 15–20%)
Small demyelinating plaques in the vestibular nuclei or fasciculus longitudinalis medialis (MLF) can be missed on standard sequences
Was the MRI done with dedicated posterior fossa sequences (thin-cut FLAIR, high-resolution T2 through brainstem)?

Recommendation: Repeat MRI at 7–10 days with dedicated brainstem/posterior fossa protocol (3T if possible) — this is standard practice for suspected posterior fossa stroke/demyelination with initial negative DWI.

Priority Investigations to Add

Investigation	Rationale
Repeat MRI brain (3T, posterior fossa protocol, DWI repeat)	Miss rate for early posterior fossa infarct/demyelination
CSF analysis (LP)	MS (oligoclonal bands, IgG index), viral/autoimmune encephalitis, Lyme
Autoimmune encephalitis panel (serum + CSF)	Anti-NMDAR, LGI1, CASPR2, GABA-B, AMPA — all can cause brainstem/vestibular symptoms
Anti-GAD65 antibodies	Cerebellar ataxia/vestibular syndrome
Serum B1 (thiamine)	Rule out Wernicke's — especially a stressed young medico with possible poor intake
VHIT with video-oculography	Formal VNG/VOG to characterize nystagmus waveform fully
ANA, ANCA, anti-dsDNA, complement	Vasculitic/CNS autoimmune etiology
Genetic testing (CACNA1A)	If EA2 suspected

Diagnostic Framework

Acute central vestibular syndrome (ACVS) with direction-changing nystagmus
                    ↓
        Structural vs. Inflammatory vs. Channelopathy
        ↙                    ↓                    ↘
Posterior fossa        MS/demyelination       EA2 / Autoimmune
infarct/mass           (repeat MRI + CSF)     encephalitis
(repeat DWI)                                  (autoimmune panel)

Management Thoughts

Stop betahistine — no role in central vestibular syndrome; may confound
Withhold further empirical steroids until LP/autoimmune workup is done — if autoimmune encephalitis is confirmed, higher-dose IVIG/plasmapheresis or rituximab will be needed
Thiamine 100mg IV empirically is low-risk and high-yield if Wernicke's hasn't been excluded
Neurology + Neuro-otology / Neuro-ophthalmology consultation urgently if not already done
If EA2 is suspected (episodic component + migraine history + calcium channelopathy), acetazolamide 250mg BD is dramatically effective and also serves as a diagnostic trial
Avoid vestibular suppressants (stemetil, cinnarizine) long-term in central lesions — they impair CNS compensation

Bottom Line

This patient has a central vestibular syndrome until proven otherwise. The direction reversal of nystagmus, negative HIT, lack of treatment response, and worsening trajectory are incompatible with a peripheral diagnosis. The normal MRI does not exclude early posterior fossa infarct, small demyelinating plaque, or autoimmune/paraneoplastic brainstem encephalitis.

Immediate next steps:

Repeat MRI (posterior fossa protocol, 3T if available)
LP (cell count, protein, glucose, oligoclonal bands, autoimmune encephalitis panel in CSF)
Serum autoimmune encephalitis panel + anti-GAD65
IV thiamine empirically
Consider acetazolamide trial if EA2 remains in differential

This young medico deserves a systematic central workup before any further empirical treatment.

This is a shared conversation. Sign in to Orris to start your own chat.